logo
Rosen Law Firm Urges Altimmune, Inc. (NASDAQ: ALT) Stockholders to Contact the Firm for Information About Their Rights

Rosen Law Firm Urges Altimmune, Inc. (NASDAQ: ALT) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK, Aug. 13, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities Altimmune, Inc. (NASDAQ: ALT) between August 10, 2023 and June 25, 2025 (the 'Class Period'). If you wish to serve as lead plaintiff, you must move the Court no later than October 6, 2025.
So What: If you purchased Altimmune securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
What to do next: To join the Altimmune class action, go to https://rosenlegal.com/submit-form/?case_id=22535 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 6, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
Details of the case: According to the lawsuit, defendants throughout the Class Period created the false impression that they possessed reliable information pertaining to the results of Altimmune's IMPACT Phase 2b MASH trial. In truth, Altimmune failed to meet an important statistical significance marker relating to the fibrosis reduction primary endpoint. Altimmune had consistently touted its inflated expectations for positive topline results from the IMPACT Phase 2b MASH trial, while concealing higher responses in the placebo group, which they knew or should have known would negatively impact the topline results. Altimmune's IMPACT Phase 2b MASH trial results fell short of reality, as shown by Altimmune's topline data, which show that the statistical significance was not achieved for the fibrosis reduction primary endpoint. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Altimmune class action, go to https://rosenlegal.com/submit-form/?case_id=22535 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com for more information.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Siemba Named a Sample Vendor in Three 2025 Gartner® Hype Cycle™ Reports for the Second Year in a Row
Siemba Named a Sample Vendor in Three 2025 Gartner® Hype Cycle™ Reports for the Second Year in a Row

Malaysian Reserve

time5 hours ago

  • Malaysian Reserve

Siemba Named a Sample Vendor in Three 2025 Gartner® Hype Cycle™ Reports for the Second Year in a Row

ATLANTA, Aug. 16, 2025 /PRNewswire/ — Siemba, a leading provider of Penetration Testing as a Service (PTaaS) and Continuous Threat Exposure Management (CTEM), announced today that it has been recognized as a Sample Vendor in the 2025 Gartner® Hype Cycle™ for Application Security, Security Operations, and Everything as a Service (XaaS) reports. This marks the second consecutive year Siemba has been included in all three Hype Cycle reports. Siemba believes this reinforces its growing role in shaping the future of offensive security. The Gartner Hype Cycle reports provide a perspective on the maturity and adoption of emerging technologies. For cybersecurity decision-makers, these reports serve as strategic guides to evaluate which innovations can address real-world risks and drive long-term security improvements. In all three reports, Siemba was identified as a Sample Vendor for Penetration Testing as a Service (PTaaS). Siemba believes that its scalable, platform-driven approach to offensive security will make it easier for organizations to secure their data and assets. 'We are proud to be recognized for the second consecutive year across three Gartner Hype Cycle reports. We believe this is a strong validation of our thesis that continuous validation and visibility are critical to modern cybersecurity,' said Kannan Udayarajan, Founder and CEO of Siemba. 'We're proud that our Full Funnel Offensive Security platform is helping organizations find, prioritize, and remediate risks faster—at the pace of their business.' The 2025 Gartner Hype Cycle for Application Security notes: 'Cybersecurity leaders must take advantage of the underlying trends in the application security space to onboard the most appropriate innovations at the optimal time for their organizational maturity.'(Source: Gartner, Hype Cycle for Application Security, 2025. Dionisio Zumerle, 22 July 2025) Gartner states 'PTaaS enables organizations to elevate their security posture with continuous assessments that integrate validation earlier in the software development life cycle as compared with traditional pentesting efforts. It gives access to real-time findings delivered through a platform, which accelerates remediation and improves collaboration efforts.' Siemba's AI driven platform combines External Attack Surface Mapping, Dynamic Application Security Testing (DAST), Automated Vulnerability Assessments, and Penetration Testing as a Service, helping enterprises operationalize CTEM programs at scale. To learn more or download the 2025 Hype Cycle for Security Operations, visit : Gartner Disclaimer Gartner, Hype Cycle for Application Security, 2025, By Dionisio Zumerle, 22 July 2025Gartner, Hype Cycle for Security Operations, 2025, By Jonathan Nunez, Darren Livingstone, 23 June 2025Gartner, Hype Cycle for XaaS, 2025, By Jason Donham, 28 July 2025 GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and is used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in our research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. About Siemba Siemba's outcome-driven Full Funnel Offensive Security model brings together Penetration Testing as a Service (PTaaS), Autonomous DAST (Dynamic Application Security Testing), Vulnerability Assessments, and External Attack Surface Mapping on one unified AI-driven platform. The platform delivers actionable data and insights enabling visibility, speed, scalability, and efficiency in Continuous Threat Exposure Management (CTEM). Enterprises, global systems integrators, government agencies and growing companies leverage Siemba to establish CTEM programs, map assets, launch and schedule autonomous assessments, conduct manual penetration testing and autonomously gather strategic threat and efficiency insights to maximize Return on Mitigation, without requiring extensive hacking knowledge or human intervention. The platform provides one-click security-framework-aligned reports, attack scoring, prioritized lists of findings with suggested remediation actions and attack proofs of concept.

Malaysia strengthens regional ties for agriculture and dairy growth
Malaysia strengthens regional ties for agriculture and dairy growth

The Sun

time8 hours ago

  • The Sun

Malaysia strengthens regional ties for agriculture and dairy growth

KUALA LUMPUR: Malaysia's strong regional partnerships, particularly within ASEAN, create vast opportunities in agriculture and dairy industries. Prime Minister Datuk Seri Anwar Ibrahim emphasised that trust from regional partners plays a key role in sector growth. He highlighted the private sector's readiness, local entrepreneurs' resilience, and modern tech like AI as driving forces behind progress. These advancements enhance productivity, strengthen dairy supply chains, and foster agricultural innovation. 'Today, I joined the local community in Pondok Tanjung for the MADANI Dairy Entrepreneur Carnival, uniting stakeholders to propel the dairy industry,' Anwar shared. He reiterated Malaysia's advantage as a resource-rich nation with strong ASEAN ties in a Facebook post. Under the MADANI Economy framework, the government, NCIA, and private sector will expand economic opportunities and job creation. Anwar also announced an immediate RM1 million allocation for infrastructure upgrades in Larut, Matang, and Selama districts. Earlier, he launched the MADANI Dairy Entrepreneur Carnival at Perak Farm Fresh Dairy Complex, focusing on modern agriculture and economic growth. - Bernama

Dow Hits Record High, Mixed Data Pressures Broader Market
Dow Hits Record High, Mixed Data Pressures Broader Market

BusinessToday

time18 hours ago

  • BusinessToday

Dow Hits Record High, Mixed Data Pressures Broader Market

Pic source: FX Empire The Dow Jones Industrial Average ended modestly higher on Aug 15 after touching a fresh intraday record, lifted by a sharp rally in UnitedHealth Group's shares, even as the S&P 500 and Nasdaq fell on mixed economic signals that clouded the Federal Reserve's (Fed) next policy move. Reuters reported that UnitedHealth jumped nearly 12%, its biggest one-day gain since March 2020, after Berkshire Hathaway disclosed a new stake in the health insurer, while Scion Asset Management also boosted its holdings. The surge helped the healthcare sector log its best weekly performance since October 2022. The Dow gained 34.86 points, or 0.08%, to close at 44,946.12. The S&P 500 slipped 0.29% to 6,449.80 and the Nasdaq Composite fell 0.40% to 21,622.98. For the week, the Dow rose 1.74%, the S&P 500 added 0.94% and the Nasdaq advanced 0.81%. The small-cap Russell 2000 outperformed with a 3.13% weekly gain. Markets remain focused on the Fed, with traders betting on a 25-basis-point rate cut in September following signs of labour market weakness and muted tariff-driven inflation. However, Chicago Fed President Austan Goolsbee urged caution, noting uneven economic data. July retail sales grew in line with forecasts, but factory output and consumer sentiment weakened under tariff pressures. Geopolitical developments also loomed large. Investors eyed a meeting between US President Donald Trump and Russian President Vladimir Putin in Alaska, seen as pivotal for Ukraine peace prospects and the outlook for crude oil prices. Trump also signalled new tariffs on steel and semiconductors could be unveiled next week. Trading volumes were lighter than average, with 16.3 billion shares changing hands across US exchanges versus a 20-session average of 18.2 billion.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store